CG Results Healthcare has advised iSafety on its acquisition by ProPharma Group

  • Service: M&A
  • Sector: Healthcare
  • Sub Sector: CROs & CMOs
  • Engagement Type: Sell Side
Aug 2021
has been acquired by
an Odyssey Investment Partners-backed company

CG Results Healthcare is delighted to announce that it has advised iSafety Systems, a provider of end-to-end pharmacovigilance and safety solutions and services, on its acquisition by ProPharma Group, the leading global provider of regulatory and compliance consulting, clinical research services, pharmacovigilance, and medical information, and a portfolio company of Odyssey Investment Partners.

Headquartered in India’s leading bio-tech hub, Hyderabad, with a multilingual cross-functional team of pharmacovigilance experts and SME’s, iSafety’s team bolsters and extends ProPharma Group’s global reach and capabilities in 130+ countries throughout the USA, Europe, Latin America and Asia-Pacific.

Sector Related Deals

Jul 2022
has divested its API site in Rhode Island, USA, to
Jun 2022
A Kester Capital-backed company
has received investment from
Jun 2022
has been acquired by
A company backed by GTCR and The Carlyle Group
Mar 2022
has divested its Ringaskiddy, Ireland, manufacturing facility
Mar 2022
has divested its Boucherville, Canada manufacturing facility
Jan 2022
has divested its API manufacturing site in Cramlington, UK, to
Jun 2021
has acquired a drug product manufacturing facility from
May 2021
has been acquired by
a Behrman Capital-backed company
Feb 2021
has been acquired by